Zmat3 Is a Key Splicing Regulator in the p53 Tumor Suppression Program.


Journal

Molecular cell
ISSN: 1097-4164
Titre abrégé: Mol Cell
Pays: United States
ID NLM: 9802571

Informations de publication

Date de publication:
05 11 2020
Historique:
received: 13 02 2020
revised: 19 08 2020
accepted: 14 10 2020
entrez: 6 11 2020
pubmed: 7 11 2020
medline: 5 1 2021
Statut: ppublish

Résumé

Although TP53 is the most commonly mutated gene in human cancers, the p53-dependent transcriptional programs mediating tumor suppression remain incompletely understood. Here, to uncover critical components downstream of p53 in tumor suppression, we perform unbiased RNAi and CRISPR-Cas9-based genetic screens in vivo. These screens converge upon the p53-inducible gene Zmat3, encoding an RNA-binding protein, and we demonstrate that ZMAT3 is an important tumor suppressor downstream of p53 in mouse Kras

Identifiants

pubmed: 33157015
pii: S1097-2765(20)30729-2
doi: 10.1016/j.molcel.2020.10.022
pmc: PMC7654708
mid: NIHMS1640952
pii:
doi:

Substances chimiques

Cell Cycle Proteins 0
RNA-Binding Proteins 0
Tumor Suppressor Protein p53 0
ZMAT3 protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

452-469.e9

Subventions

Organisme : NCI NIH HHS
ID : T32 CA009302
Pays : United States
Organisme : NCI NIH HHS
ID : F32 CA162681
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA087497
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA023100
Pays : United States
Organisme : NHGRI NIH HHS
ID : K99 HG009530
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA233944
Pays : United States
Organisme : NCI NIH HHS
ID : R35 CA197591
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests E.L.V.N. is cofounder, member of the Board of Directors, on the scientific advisory board, equity holder, and paid consultant for Eclipse BioInnovations. G.W.Y. is cofounder, member of the Board of Directors, on the scientific advisory board, equity holder, and paid consultant for Locana and Eclipse BioInnovations. G.W.Y. is a visiting professor at the National University of Singapore. Dr. Yeo’s interest(s) have been reviewed and approved by UCSD in accordance with its conflict of interest policies. S.W.L. is a member of the scientific advisory board of PMV Pharmaceuticals. The authors declare no other competing financial interests.

Références

Cell. 2019 Jan 24;176(3):564-580.e19
pubmed: 30580964
Proc Natl Acad Sci U S A. 2015 Jun 30;112(26):E3384-91
pubmed: 26080438
Nature. 2001 Apr 26;410(6832):1111-6
pubmed: 11323676
J Biol Chem. 1979 Jun 25;254(12):5184-90
pubmed: 447639
Cell. 2014 Jul 31;158(3):579-92
pubmed: 25083869
Cancer Cell. 2016 Nov 14;30(5):750-763
pubmed: 27818134
Cell Rep. 2013 May 30;3(5):1339-45
pubmed: 23665218
Nature. 2010 Nov 25;468(7323):572-5
pubmed: 21107428
Cancer Cell. 2019 Aug 12;36(2):194-209.e9
pubmed: 31408619
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):69-74
pubmed: 20018659
Nat Genet. 1996 Sep;14(1):69-77
pubmed: 8782822
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15756-61
pubmed: 19805223
Mol Cell. 2019 Oct 17;76(2):329-345
pubmed: 31626751
Nucleic Acids Res. 2015 May 19;43(9):4447-62
pubmed: 25883152
Nat Methods. 2017 Jul;14(7):737-742
pubmed: 28530655
Genome Biol. 2009;10(3):R25
pubmed: 19261174
Nat Neurosci. 2010 Jan;13(1):133-40
pubmed: 20023653
Genome Biol. 2016 Dec 16;17(1):261
pubmed: 27986087
Nat Methods. 2016 Jun;13(6):508-14
pubmed: 27018577
Cell. 2018 Aug 23;174(5):1067-1081.e17
pubmed: 30078707
Genes Dev. 2015 Jan 1;29(1):63-80
pubmed: 25561496
J Cell Biol. 2010 Oct 18;191(2):367-81
pubmed: 20937701
Nat Commun. 2016 May 10;7:11479
pubmed: 27161491
Nucleic Acids Res. 2018 Jul 2;46(W1):W537-W544
pubmed: 29790989
Nat Methods. 2016 Dec;13(12):1036-1042
pubmed: 27798611
Nat Commun. 2017 May 05;8:15178
pubmed: 28474669
Oncotarget. 2016 Jul 5;7(27):42716-42739
pubmed: 27034008
Proc Natl Acad Sci U S A. 2010 Jul 6;107(27):12186-91
pubmed: 20566848
Proc Natl Acad Sci U S A. 2015 Aug 25;112(34):E4726-34
pubmed: 26261309
Genome Biol. 2014;15(12):550
pubmed: 25516281
Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9353-8
pubmed: 15961540
Oncotarget. 2016 Jan 12;7(2):1895-911
pubmed: 26672765
Nat Rev Genet. 2016 Jul;17(7):407-421
pubmed: 27240813
Semin Cell Dev Biol. 2018 Sep;81:33-45
pubmed: 29154823
EMBO J. 1997 Jul 16;16(14):4384-92
pubmed: 9250682
Exp Dermatol. 2016 Jan;25(1):10-6
pubmed: 26479498
Am J Pathol. 2013 Jun;182(6):1996-2004
pubmed: 23578383
Nat Methods. 2009 Jun;6(6):443-5
pubmed: 19448642
Cell. 2009 May 1;137(3):413-31
pubmed: 19410540
Cancer Discov. 2019 Nov;9(11):1493-1510
pubmed: 31611195
Dev Cell. 2019 Jul 22;50(2):212-228.e6
pubmed: 31178404
Nat Protoc. 2009;4(7):1064-72
pubmed: 19561589
Nucleic Acids Res. 1995 Dec 25;23(24):5080-1
pubmed: 8559668
RNA. 2018 Mar;24(3):324-331
pubmed: 29263134
Nat Chem Biol. 2016 May;12(5):361-6
pubmed: 27018887
Genome Biol. 2020 Apr 6;21(1):90
pubmed: 32252787
Oncogene. 2014 Aug 28;33(35):4407-17
pubmed: 24469038
Methods Mol Biol. 2013;1038:171-9
pubmed: 23872975
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
J Clin Invest. 2016 Jan;126(1):68-84
pubmed: 26595814
Mol Cell. 2012 Apr 13;46(1):30-42
pubmed: 22387025
Cancer Res. 2009 Jan 1;69(1):219-26
pubmed: 19118006
Oncogene. 2015 May 28;34(22):2943-8
pubmed: 25088193
Genes Dev. 2013 May 1;27(9):1016-31
pubmed: 23651856
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Oncogene. 2010 Nov 4;29(44):5935-45
pubmed: 20697359
J Oncol. 2019 May 2;2019:7079604
pubmed: 31186638
Oncotarget. 2015 Sep 22;6(28):24611-26
pubmed: 26372730
Cell. 2012 Jun 8;149(6):1269-83
pubmed: 22682249
Oncogene. 1997 Nov 27;15(22):2699-704
pubmed: 9400996
Mol Biol Cell. 2012 May;23(10):1902-16
pubmed: 22438581
Curr Opin Cell Biol. 2018 Apr;51:65-72
pubmed: 29195118
Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):189-92
pubmed: 12502788
Nat Genet. 2017 Dec;49(12):1779-1784
pubmed: 29083409
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Nature. 2013 Oct 17;502(7471):333-339
pubmed: 24132290
Bioinformatics. 2011 Nov 15;27(22):3206-8
pubmed: 21903630
Genes Dev. 2014 Aug 15;28(16):1800-14
pubmed: 25128497
Elife. 2017 Feb 14;6:
pubmed: 28195531
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Genes Dev. 2001 Dec 15;15(24):3243-8
pubmed: 11751630
Cell Death Differ. 2006 Jun;13(6):927-34
pubmed: 16543935
Nat Genet. 2005 Jul;37(7):718-26
pubmed: 15924142
Genome Res. 2017 Oct;27(10):1645-1657
pubmed: 28904012
Nucleic Acids Res. 2002 May 1;30(9):1991-6
pubmed: 11972337
FEBS Lett. 2002 Jul 31;524(1-3):69-72
pubmed: 12135743
Nat Rev Mol Cell Biol. 2019 Jul;20(7):406-420
pubmed: 30992545
Nat Biotechnol. 2016 Jun;34(6):634-6
pubmed: 27159373
Cell. 2011 May 13;145(4):571-83
pubmed: 21565614
Nat Rev Cancer. 2014 May;14(5):359-70
pubmed: 24739573
Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2026-30
pubmed: 8134344
Cancer Cell. 2020 Aug 10;38(2):198-211.e8
pubmed: 32559497
J Clin Invest. 2018 Feb 1;128(2):760-773
pubmed: 29337302
Science. 2013 Feb 15;339(6121):819-23
pubmed: 23287718
Nat Biotechnol. 2017 May;35(5):463-474
pubmed: 28319085
Nat Med. 2018 Jul;24(7):947-953
pubmed: 29892060
Cancer Discov. 2013 Nov;3(11):1228-37
pubmed: 24145039
Nat Rev Cancer. 2006 Dec;6(12):909-23
pubmed: 17128209
Nature. 2012 Apr 18;486(7403):346-52
pubmed: 22522925
Proc Natl Acad Sci U S A. 2011 Oct 11;108(41):17123-8
pubmed: 21969549
J Biol Chem. 2000 Feb 25;275(8):5733-8
pubmed: 10681559
Cancer Cell. 2017 Oct 9;32(4):460-473.e6
pubmed: 29017057
Genes Dev. 2015 Jul 15;29(14):1576-85
pubmed: 26178787

Auteurs

Kathryn T Bieging-Rolett (KT)

Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA.

Alyssa M Kaiser (AM)

Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA.

David W Morgens (DW)

Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA.

Anthony M Boutelle (AM)

Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA.

Jose A Seoane (JA)

Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.

Eric L Van Nostrand (EL)

Department of Cellular and Molecular Medicine & Institute for Genomic Medicine, University of California San Diego, La Jolla, CA 92037, USA.

Changyu Zhu (C)

Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Shauna L Houlihan (SL)

Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Stephano S Mello (SS)

Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA.

Brian A Yee (BA)

Department of Cellular and Molecular Medicine & Institute for Genomic Medicine, University of California San Diego, La Jolla, CA 92037, USA.

Jacob McClendon (J)

Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA.

Sarah E Pierce (SE)

Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA.

Ian P Winters (IP)

Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA.

Mengxiong Wang (M)

Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA.

Andrew J Connolly (AJ)

Department of Pathology, UCSF School of Medicine, San Francisco, CA 94143, USA.

Scott W Lowe (SW)

Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Christina Curtis (C)

Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.

Gene W Yeo (GW)

Department of Cellular and Molecular Medicine & Institute for Genomic Medicine, University of California San Diego, La Jolla, CA 92037, USA.

Monte M Winslow (MM)

Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.

Michael C Bassik (MC)

Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.

Laura D Attardi (LD)

Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA 94305, USA. Electronic address: attardi@stanford.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH